Global Information
회사소개 | 문의

세계의 알레르기 진단 및 치료 시장 예측

GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET FORECAST 2018-2026

리서치사 Inkwood Research
발행일 2018년 06월 상품 코드 508242
페이지 정보 영문 159 Pages
가격
US $ 2,500 ₩ 2,801,700 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,362,100 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,043,100 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 알레르기 진단 및 치료 시장 예측 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET FORECAST 2018-2026
발행일: 2018년 06월 페이지 정보 : 영문 159 Pages

한글목차

세계의 알레르기 진단·치료 시장 전망에 대해 분석했으며, 시장의 최근 주요 촉진·억제요인, 시장 전체 및 부문·지역별 시장 동향 전망과 주요 기업 개요 등을 조사하여 전해드립니다.

제1장 분석 범위

제2장 분석 방법

제3장 개요

제4장 시장 개요

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회

제5장 알레르기 검사·치료의 발전

  • 진단 검사의 새로운 발전
  • 알레르겐 CRD
  • 치료의 진보
    • 한방약
    • 면역치료
    • B세포 에피토프 베이스 면역치료
    • 코 필터

제6장 시장 세분화

  • 세계의 알레르기 진단 시장 : 검사 종류별
    • 피부 시험
    • 항체
  • 세계의 알레르기 진단 시장 : 투여 형태별
    • 피하 투여
    • 설하 액체 투여
    • 설하 태블릿
  • 세계의 알레르기 진단 시장 : 입수 형태별
    • 처방약
    • OTC(시판)약
  • 세계의 알레르기 진단 시장 : 투여 형태별
    • 경구
    • 스프레이
    • 안구
    • 국소
  • 세계의 알레르기 진단 시장 : 제품별
    • 항히스타민제
    • 교감신경흥분약, 충혈 제거제 및 혼합약
    • 코르티코스테로이드
    • 류코트리엔
    • 비만세포 안정제

제7장 주요 분석

  • Porter의 산업 분석
  • PESTEL 분석
  • 기회 매트릭스

제8장 지역 분석

  • 아메리카
    • 미국
    • 캐나다
    • 브라질
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 러시아
    • 기타 유럽
  • 아시아태평양 지역
    • 인도
    • 중국
    • 일본
    • 호주·뉴질랜드
    • 기타
  • 중동·아프리카

제9장 경쟁 환경

  • 시장 점유율
  • 기업 개요 : 진단
  • 기업 개요 : 치료

제10장 부록

KSA 17.06.08

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

영문목차

KEY FINDINGS

The global allergy diagnostic and treatment market is expected to grow at a CAGR of 5.50% over the forecast period of 2018-2026. The growth potential for this market has increased because of various factors such as - an increase in the occurrence of allergies globally, growing environmental pollution and unmet medical needs.

MARKET INSIGHTS

On the basis of diagnosis, the global allergy diagnostic and treatment market is divided into skin testing and antibody testing. Skin testing has been popular in the market because of its quick effectiveness in identifying the allergen affecting the patient as compared to the antibody testing assay, which is used only when the patient is on any medication that might interfere with the result of the skin tests. On the basis of treatment, the market is further classified into treatment by availability, treatment by administration and treatment by products. The market can also be classified on the basis of immunotherapies into subcutaneous administration, sublingual liquid solutions and sublingual tablets.

REGIONAL INSIGHTS

The North American market is expected to show its dominance in the global allergy diagnostic and treatment market over the forecast period, as compared to other regions like Europe, Asia-Pacific, and Rest of World. Major driving factors for this region includes an increase in the prevalence of allergic diseases, growing population, and rising pollution levels. However, the fastest growth is expected from the Asia-Pacific region, due to progressing economies of countries like India, China, Japan, etc.

COMPETITIVE INSIGHTS

The major companies in the allergy diagnostics and treatment market are Beckman Coulter, Allergan Plc, Johnson & Johnson, Hitachi Chemical Diagnostics Inc, and Pfizer, amongst others. The rise in allergic diseases, increase in access and expenditure for medical insurance in the U.S coupled with economic growth in developing countries, easy access to healthcare by individuals and the availability of better diagnostic tools for allergy related problems are all acting as a driving force for the global allergy diagnostic and treatment market.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. ALLERGIC CONJUNCTIVITIS IS BECOMING INCREASINGLY PREVALENT
    • 3.2.2. SKIN PRICK TEST IS THE MOST PREVALENT TYPE OF ALLERGY TESTING
    • 3.2.3. ANTIHISTAMINES TREATMENT HOLDS THE LARGEST MARKET SHARE

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. HIGH INCIDENCES AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES
    • 4.1.2. RISING ENVIRONMENTAL POLLUTION
    • 4.1.3. HIGH USE OF TOBACCO
    • 4.1.4. PRESENCE OF HIGH UNMET MEDICAL NEEDS
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. STRINGENT REGULATIONS FOR MEDICAL DEVICES
    • 4.2.2. LACK OF AWARENESS ABOUT ALLERGIC DISEASES
    • 4.2.3. HIGH CAPITAL REQUIREMENTS
    • 4.2.4. HIGH DEGREE OF CONSOLIDATION ACTS AS AN ENTRY BARRIER FOR NEW ENTRANTS
    • 4.2.5. ADVERSE EFFECTS OF DRUGS
  • 4.3. MARKET OPPORTUNITIES
    • 4.3.1. ASIAN MARKET PRESENTS HIGH-GROWTH OPPORTUNITIES
    • 4.3.2. RISE IN AWARENESS ABOUT ALLERGIC RHINITIS
  • 4.4. MARKET CHALLENGES
    • 4.4.1. ALTERNATE THERAPIES AND DRUGS
    • 4.4.2. EASY AVAILABILITY OF GENERIC DRUGS
    • 4.4.3. INCREASING HEALTHCARE EXPENDITURE
    • 4.4.4. PATENT EXPIRIES AND COMPETITION FROM GENERIC DRUGS

5. MARKET SEGMENTATION

  • 5.1. MARKET BY TREATMENTS, DIAGNOSTICS AND IMMUNOTHERAPY 2018-2026
    • 5.1.1. TREATMENTS
      • 5.1.1.1. TREATMENT MARKET BY AVAILABILITY
      • 5.1.1.1.1. PRESCRIPTION
      • 5.1.1.1.2. OVER THE COUNTER
      • 5.1.1.2. TREATMENT MARKET BY ADMINISTRATION
      • 5.1.1.2.1. ORAL
      • 5.1.1.2.2. SPRAY
      • 5.1.1.2.3. OCULAR
      • 5.1.1.2.4. TOPICAL
      • 5.1.1.3. TREATMENT MARKET BY PRODUCTS
      • 5.1.1.3.1. ANTIHISTAMINES
      • 5.1.1.3.2. SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS
      • 5.1.1.3.3. CORTICOSTEROIDS
      • 5.1.1.3.4. LEUKOTRIENES
      • 5.1.1.3.5. MAST CELL STABILIZERS
    • 5.1.2. DIAGNOSTICS
      • 5.1.2.1. SKIN TESTING
      • 5.1.2.2. ANTIBODY
    • 5.1.3. IMMUNOTHERAPY
      • 5.1.3.1. SUBCUTANEOUS ADMINISTRATION
      • 5.1.3.2. SUBLINGUAL LIQUID SOLUTIONS
      • 5.1.3.3. SUBLINGUAL TABLETS

6. KEY ANALYTICS

  • 6.1. PORTER'S FIVE FORCE ANALYSIS
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTES
    • 6.1.3. BARGAINING POWER OF BUYERS
    • 6.1.4. BARGAINING POWER OF SUPPLIERS
    • 6.1.5. THREAT OF RIVALRY
  • 6.2. KEY BUYING CRITERIA
  • 6.3. SUPPLY CHAIN ANALYSIS
  • 6.4. PATENT ANALYSIS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. GERMANY
    • 7.2.2. FRANCE
    • 7.2.3. THE UK
    • 7.2.4. RUSSIA
    • 7.2.5. REST OF EUROPE
  • 7.3. ASIA-PACIFIC
    • 7.3.1. INDIA
    • 7.3.2. CHINA
    • 7.3.3. JAPAN
    • 7.3.4. AUSTRALIA AND NEW ZEALAND
    • 7.3.5. REST OF APAC
  • 7.4. REST OF WORLD
    • 7.4.1. MIDDLE EAST AND AFRICA
    • 7.4.2. LATIN AMERICA

8. COMPANY PROFILES

  • 8.1. ALLERGAN PLC
    • 8.1.1. COMPANY OVERVIEW
    • 8.1.2. PRODUCTION PORTFOLIO
    • 8.1.3. SCOT ANALYSIS
    • 8.1.4. STRATEGIC INITIATIVE
  • 8.2. BECKMAN COULTER
    • 8.2.1. COMPANY OVERVIEW
    • 8.2.2. PRODUCT PORTFOLIO
    • 8.2.3. SCOT ANALYSIS
    • 8.2.4. STRATEGIC INITIATIVES
  • 8.3. GLAXOSMITHKLINE PLC
    • 8.3.1. COMPANY OVERVIEW
    • 8.3.2. PRODUCT PORTFOLIO
    • 8.3.3. SCOT ANALYSIS
    • 8.3.4. STRATEGIC INITIATIVES
  • 8.4. HITACHI CHEMICAL DIAGNOSTICS INC.
    • 8.4.1. COMPANY OVERVIEW
    • 8.4.2. PRODUCT PORTFOLIO
    • 8.4.3. SCOT ANALYSIS
    • 8.4.4. STRATEGIC INITIATIVES
  • 8.5. JOHNSON & JOHNSON
    • 8.5.1. COMPANY OVERVIEW
    • 8.5.2. PRODUCT PORTFOLIO
    • 8.5.3. SCOT ANALYSIS
    • 8.5.4. STRATEGIC INITIATIVES
  • 8.6. MERCK
    • 8.6.1. COMPANY OVERVIEW
    • 8.6.2. PRODUCT PORTFOLIO
    • 8.6.3. SCOT ANALYSIS
    • 8.6.4. STRATEGIC MOVES
  • 8.7. PFIZER
    • 8.7.1. COMPANY OVERVIEW
    • 8.7.2. PRODUCT PORTFOLIO
    • 8.7.3. SCOT ANALYSIS
    • 8.7.4. STRATEGIC INITIATIVES
  • 8.8. SANOFI
    • 8.8.1. COMPANY OVERVIEW
    • 8.8.2. PRODUCT PORTFOLIO
    • 8.8.3. SCOT ANALYSIS
    • 8.8.4. STRATEGIC INITIATIVES
  • 8.9. THERMO FISHER DIAGNOSTICS
    • 8.9.1. COMPANY OVERVIEW
    • 8.9.2. PRODUCT PORTFOLIO
    • 8.9.3. SCOT ANALYSIS
    • 8.9.4. STRATEGIC INITIATIVES
  • 8.10. F. HOFFMANN-LA ROCHE LTD
    • 8.10.1. COMPANY OVERVIEW
    • 8.10.2. PRODUCT PORTFOLIO
    • 8.10.3. SCOT ANALYSIS
    • 8.10.4. STRATEGIC INITIATIVES
  • 8.11. MYLAN N.V.
    • 8.11.1. COMPANY OVERVIEW
    • 8.11.2. PRODUCT PORTFOLIO
    • 8.11.3. SCOT ANALYSIS
    • 8.11.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 2 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY TREATMENTS, DIAGNOSTICS AND IMMUNOTHERAPY 2018-2026 ($ MILLION)
  • TABLE 3 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY AVAILABILITY 2018-2026 ($ MILLION)
  • TABLE 4 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY ADMINISTRATION 2018-2026 ($ MILLION)
  • TABLE 5 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN TREATMENTS BY PRODUCTS 2018-2026 ($ MILLION)
  • TABLE 6 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN DIAGNOSTICS 2018-2026 ($ MILLION)
  • TABLE 7 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET IN IMMUNOTHERAPY 2018-2026 ($ MILLION)
  • TABLE 8 NORTH AMERICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • TABLE 9 EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • TABLE 10 ASIA PACIFIC ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • TABLE 11 REST OF THE WORLD ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE LIST
  • FIGURE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 2 GLOBAL TREATMENTS MARKET IN PRESCRIPTION 2018-2026 ($ MILLION)
  • FIGURE 3 GLOBAL TREATMENTS MARKET IN OVER THE COUNTER 2018-2026 ($ MILLION)
  • FIGURE 4 GLOBAL TREATMENTS MARKET IN ORAL 2018-2026 ($ MILLION)
  • FIGURE 5 GLOBAL TREATMENTS MARKET IN SPRAY 2018-2026 ($ MILLION)
  • FIGURE 6 GLOBAL TREATMENTS MARKET IN OCULAR 2018-2026 ($ MILLION)
  • FIGURE 7 GLOBAL TREATMENTS MARKET IN TOPICAL 2018-2026 ($ MILLION)
  • FIGURE 8 GLOBAL TREATMENTS MARKET IN ANTIHISTAMINES 2018-2026 ($ MILLION)
  • FIGURE 9 GLOBAL TREATMENTS MARKET IN SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS 2018-2026 ($ MILLION)
  • FIGURE 10 GLOBAL TREATMENTS MARKET IN CORTICOSTEROIDS 2018-2026 ($ MILLION)
  • FIGURE 11 GLOBAL TREATMENTS MARKET IN LEUKOTRIENES 2018-2026 ($ MILLION)
  • FIGURE 12 GLOBAL TREATMENTS MARKET IN MAST CELL STABILIZERS 2018-2026 ($ MILLION)
  • FIGURE 13 GLOBAL DIAGNOSTICS MARKET IN SKIN TESTING 2018-2026 ($ MILLION)
  • FIGURE 14 GLOBAL TREATMENTS MARKET IN ANTIBODY 2018-2026 ($ MILLION)
  • FIGURE 15 GLOBAL TREATMENTS MARKET IN SUBCUTANEOUS ADMINISTRATION 2018-2026 ($ MILLION)
  • FIGURE 16 GLOBAL TREATMENTS MARKET IN SUBLINGUAL LIQUID SOLUTIONS 2018-2026 ($ MILLION)
  • FIGURE 17 GLOBAL TREATMENTS MARKET IN SUBLINGUAL TABLETS 2018-2026 ($ MILLION)
  • FIGURE 18 KEY BUYING CRITERIA OF ALLERGY DIAGNOSTICS AND TREATMENT MARKET
  • FIGURE 19 THE UNITED STATES ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 20 CANADA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 21 PERCENTAGE OF PEOPLE SUFFERING FROM SEVERE FOOD ALLERGY IN CANADA 2017
  • FIGURE 22 GERMANY ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 23 FRANCE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 24 THE UNITED KINGDOM ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 25 RUSSIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 26 REST OF EUROPE ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 27 INDIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 28 CHINA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 29 JAPAN ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 30 AUSTRALIA AND NEW ZEALAND ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 31 REST OF APAC ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 32 MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
  • FIGURE 33 LATIN AMERICA ALLERGY DIAGNOSTIC AND TREATMENT MARKET 2018-2026 ($ MILLION)
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
La Merie Publishing
BCC Research